The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Praill Anthony Scott since 2014.
This trader's CIK number is 1332948.
At the time of last reporting, Praill Anthony Scott was the Chief Financial Officer of Kintara Therapeutics, Inc.. (stock ticker symbol KTRA).
Also see all insider trading activities at Kintara Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | KTRA | 28,700 | $19,429 | 0 | $0 | 0 | $0 |
| 2017 | KTRA | 31,167 | $49,861 | 0 | $0 | 0 | $0 |
| 2015 | KTRA | 50,000 | $30,000 | 0 | $0 | 0 | $0 |
| 2014 | KTRA | 10,000 | $13,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-08 | KTRA | Buy | 28,700 | .68 | 19,429 |
| 2017-10-05 | DMPI | Buy | 17,500 | .85 | 14,910 |
| 2017-06-26 | DMPI | Buy | 4,167 | 3.60 | 15,001 |
| 2017-06-06 | DMPI | Buy | 9,500 | 2.10 | 19,950 |
| 2015-07-16 | DMPI | Buy | 50,000 | .60 | 30,000 |
| 2014-03-18 | DMPI | Buy | 10,000 | 1.30 | 13,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Praill Anthony Scott (Chief Financial Officer of Kintara Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.